ziopharm oncology inc (ZIOP:NASDAQ CM)
James O. Armitage M.D., F.A.C.P., F.R.C.P.
Member of Scientific/Medical Advisory Board, ZIOPHARM Oncology, Inc.
|Age||Total Calculated Compensation||This person is connected to 38 board members in 4 different organizations across 3 different industries.|
See Board Relationships
Dr. James O. Armitage, M.D., F.A.C.P., F.R.C.P., served as Dean of College of Medicine of University of Nebraska Medical Center from 2000 to 2003. Dr. Armitage served at the University of Nebraska Medical Center in a variety of leadership roles and served as its Vice Chairman of the Department of Medicine from 1982 to 1990 and Henry J. Lehnhoff Chairman of Department of Internal Medicine from 1990 to 1999. He served as President of ASCO. He served as Director of the ...
Parris BuildingPhone: 617-259-1970
Boston, Massachusetts 02129
Board Members Memberships*
Former Director and Member of Science & Technology Committee
Director and Member of Compensation Committee
University of Nebraska - Lincoln
University of Nebraska, Omaha
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Douglas J. Swirsky CPA, CFA||Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Corporate Secretary and Director|
|Jeffrey D. Abbey MBA, J.D.||Chief Executive Officer, President and Director|
Argos Therapeutics, Inc.
|Mark R. Baker J.D.||Chief Executive Officer, Director and Member of Science & Strategy Committee|
Progenics Pharmaceuticals, Inc.
|Daniel J. O’Connor Esq.||Chief Executive Officer, President and Director|
|William D. Clark||Chief Executive Officer, President and Director|
Genocea Biosciences, Inc.
|$334.3K||Compensation as of Fiscal Year 2013.|